1Kempf B E,Vogt P K.A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma[].Cell Growth and Differentiation.1999
2Anastasi S,Giordano S,Sthandier O,et al.A natural hepatocyte growth fastor scatter factor autocrine loop in myoblast cells and the effect of the constitutive met kinase activation on myogemc differentiation[].The Journal of Cell Biology.1997
3Athale UH,Shurtleff SA,Jenkins JJ,et al.Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors,and desmoplasticsmall round cell tumor[].Journal of Pediatric Hematology Oncology.2001
4Wang W,Kumar P,Wang W,et al.Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma[].Cancer Research.1998
5Barr FG,Nauta LE,Hollows JC.Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma[].Cancer Genetics and Cytogenetics.1998
6Hollenbach A D,Sublett J E,Mcpherson C J,et al.The Pax3FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx[].EMBO Journal.1999
7Dockhom-Dwomiczak B,Schafer KL,Blasius S,et al.Assessment of molecular genetic detection of chromosome translocations in the differential diagnosis of pediatric sarcomas[].Klinische Padiatrie.1997
8Barr FG.The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma[].Cancer Research.1999
9Tobar A,Avigad S,Zoldan M,et al.Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma[].Diagnostic Molecular Pathology.2000
10Fredericks WJ,Ayyanathan K,Rauscher FJ,et al.Regulating the neoplastic phenotype using engineered transcriptional repressors[].Cancer Letters.2001